Lv2
160 积分 2024-12-18 加入
Potential drugs for reducing the occurrence of immune checkpoint inhibitor-induced interstitial lung disease: an exploratory study using the JADER and FAERS databases
2天前
已完结
Post-Marketing Safety Surveillance of Adalimumab, Secukinumab, and Infliximab in Hidradenitis Suppurativa: An Analysis of the FDA Adverse Events Reporting System (FAERS) Database
10天前
已完结
Ustekinumab Safety in Pregnancy: A Comprehensive Review
30天前
已完结
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero
30天前
已完结
Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum
30天前
已完结
Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO Registry
30天前
已完结
Safety of Ustekinumab and Vedolizumab During Pregnancy—Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study
30天前
已完结
Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy with Inflammatory Bowel Disease: Stop the Disease, not the Drug!
30天前
已完结
A case of atopic eczema treated safely with dupilumab during pregnancy and lactation
30天前
已完结
Towards a more comprehensive evaluation: Addressing limitations in the study of dupilumab and pregnancy outcomes
30天前
已完结
皖公网安备34019202002308
